MEDICA 2016: Skin protection in triplicate
„Our skin has a natural protective function for our body. This protection decreases especially by daily work with medical gloves, disinfection and cleaning and skin may dehydrate. By offering this skin analysis we want to create awareness for the burden of skin and particularly hands in the medical routine.” says Jens Schumacher, CEO of Dr. Schumacher GmbH.
Disinfection: Regular skin and hand disinfection are mandatory in daily healthcare. While disinfecting their hands before and after any contact with patients, doctors and nursing staff reach a high hygienic status, but strain their skin equally. Skin and hand disinfection products of Dr. Schumacher are very skin-friendly and guarantee a safe and rapid disinfection. Regarding hand disinfection especially the ASEPTOMAN® series is suitable for every skin type and requirement.
Cleaning: Among disinfection products items for skin and hand cleaning are also offered. Descosan Kamillenduft is a skin-friendly washing lotion with mild surfactants. Optimal ingredients, lanolin, refatting and humectant components protect the physiological integrity of the skin. It is free from colourants and has a mild chamomile scent.
Skin care: Dr. Schumacher developed the hypoallergenic prolind sensitive skin care series especially for sensitive and allergic skin. The wide portfolio includes lotions, skin care and skin protection creams which are divided into water-in-oil-emulsions and oil-in-water emulsions. Especially hypoallergenic prolind Intensiv-Pflegecreme sensitive nourishes lastingly and is suited even for atopic and allergic skin. This water-in-oil-emulsion is free from perfume, colourants and preservatives. All products are pH-neutral and may be used by medical staff as well as patients.
Take care when using disinfectants. Always read the label and product information prior to use.
Dr. Schumacher GmbH
For almost 40 years Dr. Schumacher GmbH is an internationally recognised specialist for the development and production of disinfection, hygiene and care products in all medical areas. Employing more than 1,000 people in eight countries the owner-managed German company with headquarter in Malsfeld/Hesse is producing disinfection and cleaning products for skin, hands, instruments and surfaces. Dr. Schumacher is one of the biggest manufacturers of wet and dry wipe systems in Europe with an own production of soft cloth systems and wet wipes. A distribution network in about 70 countries emphasises the international scope of the hygiene specialist.
Dr. Schumacher GmbH
Am Roggenfeld 3
T +49 5664 9496-729
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MEDICA 2016: Skin protection in triplicate here
News-ID: 386666 • Views: …
More Releases from Dr. Schumacher GmbH
For the fourth time already, Dr. Schumacher joins other companies at the ICPIC i …
Malsfeld/Geneva - Dr. Schumacher will participate in the 5th International Conference on Prevention & Infection Control (ICPIC) in Geneva/Switzerland from September 10th to 13th 2019 – celebrating the 10-year anniversary of ICPIC at the International Conference Center in Geneva, just next to the Place des Nations. The ICPIC offers a unique forum for participants to exchange both their knowledge and experience in the prevention of healthcare-associated infections and control of antimicrobial
‘Discover new market potentials’: Dr. Schuhmacher at PLMA 2019 in Amsterdam
Malsfeld, Germany – As in previous years, Dr. Schumacher will be exhibiting at this year’s edition of PLMA, the most important international trade fair for private label. The ‘World of Private Label’ fair will take place at Amsterdam’s RAI Exhibition Center on May 21 and 22, 2019. Some 15,000 trade visitors from 120 countries are expected to attend. Under the tagline “Discover new market potentials,” Dr. Schumacher GmbH will be presenting
A new formula against Multidrug-Resistant Organisms (MDROs)
Our DECONTAMAN PRE product range for skin and hand decontamination including hygienic, full body washing offers fast and complete efficacy as well as excellent skin compatibility. In order to meet the high standards and requirements of our customers and also their future needs, Dr. Schumacher GmbH has released updated and optimized formulations for the whole range. Infections in the medical sector caused by multidrug-resistant organisms (MDROs) pose a serious problem
Resounding success in Dubai
Dubai/Malsfeld – Dr. Schumacher GmbH has been a regular guest at Arab Health for more than a decade now. With over 4,150 exhibitors, the international event, held this year from 28th to 31st January in Dubai, is one of the world’s largest health trade fairs. This year, Dr. Schumacher GmbH managed to improve on the success of previous years yet again and welcomed a wide variety of trade fair visitors
More Releases for Skin
Bellueur Skin Canada Review: Does Bellueur Skin Really Work?
Bellueur Skin Canada Only: https://rebrand.ly/01b756 Best Anti Aging Cream US Only: https://rebrand.ly/eee7f0 Are you feeling disappointed with your facial skin? Oh, not only you, many of us nowadays feel the same. Everybody wants healthy and bright skin. No one likes dull, wrinkled, and tainted skin. As we grow older our skin starts to lose firmness and gets wrinkled and dull. The Epidermis, the outermost layer of our skin keeps the moisture in
Juventus Skin Cream-Does Juventus Skin Cream Work-Complete Info
You Might Have asked why a Few Folks Juventus Skin Possess such Flawless and Flawless pores and skin. What exactly do they actually do and what things do they utilize to earn their skin glow shiny? During our teenagers, have to have skin that is exceptional. Whatever the instance, together with all of the age this is growing, it begins to decompose in a extraordinary way. Both tremendous desires are
Global Anti-Aging Facial Mask Sales Market For End Users/Applications - Oil Skin …
Researchmoz added Most up-to-date research on "Global Anti-Aging Facial Mask Sales Market For End Users/Applications - Oil Skin, Normal Skin, Dry Skin and Combination Skin" to its huge collection of research reports. In this report, the global Anti-Aging Facial Mask market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and
Australia Tissue Engineered - Skin Substitutes Market 2024: Biologic Skin Substi …
"The Latest Research Report Australia Tissue Engineered - Skin Substitutes Market Outlook to 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Skin Substitutes Market GlobalDatas new report, Australia Tissue Engineered - Skin Substitutes Market Outlook to 2024, provides key market data on the Australia Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in
Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017
Orbis Research delivers key insights on the global Complicated Skin And Skin Structure Infections (cSSSI) market in a new report titled “Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017” In this report, Orbis Research sheds light on the various factors and trends impacting market growth over the forecast period (2017 – 2022). “Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs
Latest Report: Global Skin And Skin Structure Infections (SSSI) Market
Marketresearchreports.biz has added a new research report on the "Skin And Skin Structure Infections (SSSI)-API Insights, 2017" to its collection. The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API